title: Biohydrogels with magnetic nanoparticles as crosslinker: characteristics and potential use for controlled antitumor drug-delivery.
abstract: Hybrid magnetic hydrogels are of interest for applications in biomedical science as controlled drug-delivery systems. We have developed a strategy to obtain novel hybrid hydrogels with magnetic nanoparticles (NPs) of CoFe(2)O(3) and Fe(3)O(4) as crosslinker agents of carboxymethylcellulose (CMC) or hyaluronic acid (HYAL) polymers and we have tested these systems for controlled doxorubicin release. The magnetic NPs are functionalized with (3-aminopropyl)trimethoxysilane (APTMS) in order to introduce amino groups on the surface. The amino coating is determined and quantified by standard Fourier transform infrared spectroscopy and X-ray photoelectron spectroscopy methods, and by cyclic voltammetry, a novel approach that permits us to look at the solution properties of the functionalized NPs. The gel formation involves the creation of an amide bond between the carboxylic groups of CMC or HYAL and the amine groups of functionalized NPs, which work as crosslinking agents of the polymer chains. The hybrid hydrogels are chemically and morphologically characterized. The rheological and the water uptake properties of the hydrogels are also investigated. Under the application of an alternating magnetic field, the CMC-HYAL hybrid hydrogel previously loaded with doxorubicin shows a drug release greater than that showed by the CMC-HYAL hydrogel crosslinked with 1,3-diaminopropane. In conclusion, the presence of magnetic NPs makes the synthesized hybrid hydrogels suitable for application as a drug-delivery system by means of alternating magnetic fields.
authors.affiliation: Interuniversity Research Centre for Advanced Medical Systems (CRISMA), Viale Matteotti 15, 53034 Colle di Val d'Elsa, Siena, Italy. rolando.barbucci@unisi.it
authors.forename: Rolando
authors.initials: R
authors.lastname: Barbucci
authors.forename: Gabriele
authors.initials: G
authors.lastname: Giani
authors.forename: Serena
authors.initials: S
authors.lastname: Fedi
authors.forename: Severino
authors.initials: S
authors.lastname: Bottari
authors.forename: Mario
authors.initials: M
authors.lastname: Casolaro
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000737:chemistry*; D002266:Carboxymethylcellulose Sodium / Q000737:chemistry; D003432:Cross-Linking Reagents / Q000737:chemistry*; D003692:Delayed-Action Preparations / Q000138:chemical synthesis / Q000737:chemistry; D003959:Diamines / Q000737:chemistry*; D006801:Humans; D006820:Hyaluronic Acid / Q000737:chemistry; D020100:Hydrogels / Q000138:chemical synthesis / Q000737:chemistry; D060526:Magnetic Fields; D058185:Magnetite Nanoparticles / Q000737:chemistry*; D009369:Neoplasms / Q000178:diet therapy
chemical_list: D000970:Antineoplastic Agents; D003432:Cross-Linking Reagents; D003692:Delayed-Action Preparations; D003959:Diamines; D020100:Hydrogels; D058185:Magnetite Nanoparticles; D006820:Hyaluronic Acid; C009475:trimethylenediamine; D002266:Carboxymethylcellulose Sodium